{"timestamp": 1771609340.3263714, "value": {"ticker": "TSHA", "company_name": "Taysha Gene Therapies, Inc.", "short_name": "Taysha Gene Therapies, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 1272355456, "float_shares": 171191391, "shares_outstanding": 273919373, "short_ratio": 20.39, "short_percent_of_float": 0.22709998, "shares_short": 55693756, "shares_short_prior": 56034955, "insider_percent_held": 0.11135, "institution_percent_held": 0.99854, "total_cash": 297344000, "total_debt": 69083000, "total_revenue": 6310000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -16.18542, "debt_to_equity": 31.546, "current_ratio": 10.476, "book_value": 0.799, "price_to_book": 5.8135166, "operating_cashflow": -84676000, "free_cashflow": -49377876, "price": 4.645, "52w_high": 6.02, "52w_low": 1.05, "avg_volume": 3028305, "avg_volume_10d": 2303840, "full_time_employees": 73, "audit_risk": 7, "overall_risk": 10}}